The digital era is booming, and the chemical and pharmaceutical sectors must keep up.
Many drugs, especially newly developed substances, have lower solubility and lower permeability, which limits their oral bioavailability.
The Ministry of Business and Labour of Catalonia, the Honorable Roger Torrent i Ramió, authorities of Catalonia and the CEO of AGC Pharma Chemicals Europe, Akihiro Kadokura walking around the manufact
The project of this Spanish and Japanese small molecule CDMO (Contract Development & Manufacturing Organization) will bring an investment of 100 million US dollars, increasing a 30% API production cap
AGC Pharma Chemicals Europe participates in the SIEMENS Neo Era Event with a talk about digitalization as a reference in implementing the electronic batch record, being a pioneer in the pharma-chemica
AGC Pharma Chemicals Europe has completed the investment of the in-house micronization facility which will broaden its service level for customers.
AGC has decided to expand the production lines at the Kaminaka Plant of AGC Wakasa Chemicals. The additional capacity, that shall start operation early 2024, will increase AGC Wakasa Chemicals’ manufa
AGC Pharma Chemicals Europe participated in the Event Digitalization of Pharma Operations 4.0, hosted by OYTEC, last October 21st, and shared with the pharma community the exciting trip towards the Di
AGC Pharma Chemicals, a business division of Japan´s AGC Group, has more than 40 years of CDMO experience in the small molecules business.
The Keicho Awards, which were held today, highlight innovation and technology as promotors of business relations between Spain and Japan.